I

InMed Pharmaceuticals
D

INM

3.16500
USD
-0.23
(-6.64%)
مغلق
حجم التداول
182
الربح لكل سهم
-21
العائد الربحي
-
P/E
-0
حجم السوق
3,820,744
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: InMed Pharmaceuticals Inc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.